FDA Inspection 1309492 - Naresh P. Singh, MD - March 26, 2026

Record Details

This FDA Inspection record concerns Naresh P. Singh, MD, with an inspection on March 26, 2026, issued by the San Francisco District Office, covering human drugs.

Company: Naresh P. Singh, MD
Inspection Date: March 26, 2026
Product Type: Human Drugs
Office: San Francisco District Office
Person: Scott N. Lim (Issuing Officer)

View Company Profile

ID · 509ee54d-f488-478a-b02b-8106b9d7fb98

Inspection Facts

Inspection number: 1309492
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Naresh P. Singh, MD

FDA Inspection

Naresh P. Singh, MDMarch 26, 2026